U.S. health chiefs vow to identify autism 'causes' amid sharp criticism from medical community

U.S. health officials, led by Health Secretary Robert F. Kennedy Jr., announced this week that their team will publish a list of environmental exposures they say are "certainly causing autism" by the end of the month. Kennedy said the review will identify the factors responsible for rising autism diagnoses and that eliminating those exposures will end what he and President Donald Trump have described as an "autism epidemic."

The announcement followed remarks from Trump last week, in which he described the increase in autism diagnoses in the United States and elsewhere as "a tremendous horror show." Kennedy told reporters the administration’s probe would result in a definitive catalogue of harmful environmental agents tied to autism and pledged swift action to remove them.

The public declaration prompted immediate and forceful criticism from medical leaders, autism researchers and advocacy groups, who said the timetable and rhetoric are misleading and potentially harmful. Critics cautioned that portraying autism as a single avoidable condition risks increasing stigma against autistic people and could encourage parents to pursue unproven or dangerous interventions.

"Autism is a neurodevelopmental condition with a complex and multifactorial etiology," said one autism researcher who requested anonymity to speak broadly about the scientific landscape. "Genetics, prenatal and perinatal factors, and diverse environmental influences are all part of the evidence base. There is no consensus that a short review can definitively identify 'the' causes."

Medical experts highlighted that some campaigners repeatedly point to vaccines as a principal cause of autism, despite repeated large-scale studies finding no causal link. They also warned that dramatic claims about environmental "toxins" or single causative agents could lead families toward unproven treatments, including restrictive diets and dangerous detox regimens that have been promoted in some circles.

Advocacy organizations for autistic people urged the administration to prioritize services and supports rather than framing autism primarily as a condition to be "cured." They said research and policy should focus on access to behavioral and educational services, healthcare, employment support and protections against discrimination.

Health officials have not released details about the methods, data sources or scientific advisory panels that will guide the review. That lack of transparency contributed to skepticism among scientists, who said establishing causation requires rigorous, peer-reviewed research and replication over time. Many noted that credible scientific consensus typically emerges from multiple independent studies and systematic reviews, not from a single administrative report produced on an accelerated schedule.

Experts also cautioned about unintended consequences if the government were to single out specific exposures without robust evidence. Past episodes in public health have shown that premature or poorly supported claims can fuel misinformation, divert resources from effective interventions and prompt individuals to seek unproven therapies.

Autism prevalence estimates have risen in recent decades in part because of changes in diagnostic criteria, increased awareness, and improved detection, experts say, complicating efforts to attribute increases to environmental causes alone. Researchers emphasize that disentangling diagnostic trends from true changes in incidence is a challenging task that typically requires longitudinal population studies.

The administration’s pledge has raised questions about what actions might follow publication of the list and how recommendations would be implemented. Medical and advocacy groups called for the report to be subjected to independent scientific review and for policymakers to engage with researchers, clinicians and autistic people and their families before taking regulatory or public-health steps.

For now, the announcement has intensified debate over how government should address autism. As the promised deadline approaches, both supporters of the initiative and its critics say they will be watching the methods, evidence and proposed actions closely, while urging that any response be guided by rigorous science and attention to the needs and rights of autistic people.